Digital Biomarkers Market Size, Trends, Growth Factors, Regional Segment Revenue Analysis, 2035
Digital Biomarkers Market Overview
In pursuit of building a competitive edge in Digital biomarkers market stakeholders are actively upgrading their existing capabilities to enhance their Product Portfolios and comply with the evolving industry benchmarks.
The Digital Biomarkers Market is estimated to be USD 5.55 billion in 2024 and is projected to reach USD 35.8 billion in 2035.
Digital Biomarkers Market Segmentation
Digital Biomarkers Market include Distribution by Type of Product (Software / Applications, Wearables, and Others), Purpose of Solution (Diagnosis, Early Detection, Monitoring, and Predictive Insights), Type of Biomarker (Cognitive, Idiosyncratic, Physiological, Vocal, and Others), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Disorders, Mental Health Disorders, Neurological Disorders, Respiratory Disorders, Substance Abuse Disorders and Others), Business Model (B2B and B2C) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Rest of the World).
The digital biomarker solution offered by Altoida, MSIntuit CRC (Owkin), ActiGraph LEAP (ActiGraph) and ObvioGo (ObvioHealth) emerged as the most competent digital biomarker solutions in terms of product portfolio strength.
Digital Biomarkers Market Key Players
Key players in digital biomarkers domain are AliveCor, BACtrack, Biogen, BioSensics, empatica, Eyenuk, Feel Therapeutics, icometrix, and Quibim.
Further, the digital biomarker solution offered by Altoida is an AI-powered tool that enables predictive diagnosis of Alzheimer's disease through a smartphone / tablet application; the company claims to have developed this solution, owing to its cognitive research of 20 years. Notably, it has been validated in over 200 independent studies, and is currently being used in clinics across Brazil, Europe and the US. Further, Owkin’s MSIntuit CRC is a deep learning software that is used by healthcare professionals for analyzing (risk assessment, screening, diagnosis and prognosis) primary coleorectal cancer, by identification of imaging biomarkers.
Digital Biomarkers Market Geographical Regions
Key Geographical Regions of Digital Biomarkers Market include North America, Europe, Asia-Pacific, Middle East and North Africa, and Rest of the World.
Further, over 765 patents related to digital biomarkers have been filed / granted, indicating the heightened pace of innovation in this domain. Around 75% of the patents in this domain were patent applications (not having received approval yet).Further, 50% of the patents were filed / granted in North America, followed by 34% filed / granted in WIPO and 8% each in Europe and Asia-Pacific. Despite the large number of patents that have been filed recently (and hence having a long remaining patent life), only 3% of the total patents filed in this domain have a significantly higher relative valuation. This is primarily because of the relatively low citations of the patents that have been filed recently, leading to low patent value.
Presently, digital biomarker solutions in North America capture the around 45% share of the overall digital biomarkers market, and this trend is unlikely to change in the future. This is followed by the market share captured by Europe. Further, the digital biomarker solutions market in Asia-Pacific is anticipated to grow at a higher pace, having a CAGR of over 21%, during the forecast period.
Considering the enormous opportunities associated with this segment of biomarkers, investors have readily extended funds, worth over USD 3 billion (across 160 instances), during the period 2015-2024 (till February). The maximum number of funding instances were reported in 2023, amounting to approximately USD 194 million. Further, around 50% of the instances were of venture capital financing (amounting to over USD 2.6 billion).
Browse Complete Report at: https://www.rootsanalysis.com/reports/digital-biomarkers-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture catalysts, and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organizations worldwide.
All our analysts are trained to produce high-quality research work. They are continuously mentored by senior experts to present an original, unbiased and informed perspective on pressing issues in the industry. On any particular subject, we bring together the best available resources to ensure highest quality in all our reports.
https://www.bloguemac.com/group/pacientes-embarazadas/discussion/aca31c93-4947-40a5-9a57-c625016404db
https://www.maanation.com/post/148347_single-use-bioreactors-market-overview-read-more-https-www-rootsanalysis-com-rep.html
https://kryza.network/post/100352_single-use-bioreactors-market-overview-read-more-https-www-rootsanalysis-com-rep.html#google_vignette
https://www.bookemon.com/member-home/rupalimehta/1052017
https://vurl.com/8Ozxl
https://blog.dotcomsecrets.com/get-started/#comment-60399
https://tawasol1.mn.co/posts/57888205
https://www.dli.tech.cornell.edu/post/section-230-revisited-web-freedom-vs-accountability?commentId=9b58f33e-6243-4098-aa61-10563eae3eeb
https://www.akal-icr.com/profile/rupali14mehta/profile
https://www.premiersolartexas.com/profile/rupali14mehta/profile
https://sites.northwestern.edu/situationcritical/2016/10/14/attempting-to-create-art-in-a-vacuum/comment-page-6/#comment-192482
https://wp.wwu.edu/zurcherportfolio/2018/06/08/helpful-resources/#comment-36396
https://icon4.biology.ualberta.ca/keynote-speakers/#comment-523214
https://crypto-potential.com/user/rupali-mehta
https://gbcame.org/community/profile/38176/
https://reach.at/rupalimehta
https://maltajobs.com.mt/author/rupali14mehta/
Contact Details
Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/